Investigational Drugs
Investigational drugs for NAFLD are derived from global clinical trials with the latest progress, and detailed drug properties are extracted from DrugBank and PubChem. For each drug, related therapeutic strategies, targets, and clinical trials in NAFLDkb are presented with knowledge graphs.
stats1
stats2
Search for:
inflammatory59 records.
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| D527 | EPA/DHA | Supplement | DB11133 | -- | -- | Under clinical trials | Details |
| D603 | Ravoxertinib | Chemical drug | -- | Extracellular signal-regulated MAP kinase inhibitors; Mitogen activated protein kinase 3 inhibitors; Mitogen-activated protein kinase 1 inhibitors | Anti-inflammatory | Under investigation | Details |
| D604 | FR180204 | Miscellany | -- | -- | Anti-inflammatory | Under investigation | Details |
| D605 | Sulforaphen | Miscellany | -- | NLRP3 inhibitor | Anti-inflammatory | Under investigation | Details |
| D606 | Sparstolonin B | Miscellany | -- | TLR4 antagonist | Anti-inflammatory | Under investigation | Details |
| D607 | Anti-IL11 | Biological drug | -- | IL11 antibody | Anti-inflammatory | Under investigation | Details |
| D608 | anti-IL11RA | Biological drug | -- | IL11 antibody | Anti-inflammatory | Under investigation | Details |
| D609 | Annexin A5 | Miscellany | -- | -- | Anti-inflammatory | Under investigation | Details |
| D610 | Thalidomide | Chemical drug | -- | Tumour necrosis factor inhibitors | Antifibrotics; Antileprotics; Antineoplastics; Anti-inflammatory | Under investigation | Details |